Stromal regulation of vessel stability by MMP14 and TGFβ

Nor E. Sounni, Kerstin Dehne, Leon Van Kempen, Mikala Egeblad, Nesrine I. Affara, Ileana Cuevas, Jane Wiesen, Simon Junankar, Lidiya Korets, Jake Lee, Jennifer Shen, Charlotte J. Morrison, Christopher M. Overall, Stephen M. Krane, Zena Werb, Nancy Boudreau, Lisa M. Coussens

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Innate regulatory networks within organs maintain tissue homeostasis and facilitate rapid responses to damage. We identified a novel pathway regulating vessel stability in tissues that involves matrix metalloproteinase 14 (MMP14) and transforming growth factor beta 1 (TGFβ1). Whereas plasma proteins rapidly extravasate out of vasculature in wild-type mice following acute damage, short-term treatment of mice in vivo with a broadspectrum metalloproteinase inhibitor, neutralizing antibodies to TGFβ1, or an activin-like kinase 5 (ALK5) inhibitor significantly enhanced vessel leakage. By contrast, in a mouse model of age-related dermal fibrosis, where MMP14 activity and TGFβ bioavailability are chronically elevated, or in mice that ectopically express TGFβ in the epidermis, cutaneous vessels are resistant to acute leakage. Characteristic responses to tissue damage are reinstated if the fibrotic mice are pretreated with metalloproteinase inhibitors or TGFβ signaling antagonists. Neoplastic tissues, however, are in a constant state of tissue damage and exhibit altered hemodynamics owing to hyperleaky angiogenic vasculature. In two distinct transgenic mouse tumor models, inhibition of ALK5 further enhanced vascular leakage into the interstitium and facilitated increased delivery of high molecular weight compounds into premalignant tissue and tumors. Taken together, these data define a central pathway involving MMP14 and TGFβ that mediates vessel stability and vascular response to tissue injury. Antagonists of this pathway could be therapeutically exploited to improve the delivery of therapeutics or molecular contrast agents into tissues where chronic damage or neoplastic disease limits their efficient delivery.

Original languageEnglish (US)
Pages (from-to)317-332
Number of pages16
JournalDMM Disease Models and Mechanisms
Volume3
Issue number5-6
DOIs
StatePublished - May 2010

Fingerprint

Matrix Metalloproteinase 14
Tissue
Activins
Metalloproteases
Transforming Growth Factor beta
Tumors
Tissue homeostasis
Phosphotransferases
Blood Vessels
Hemodynamics
Skin
Neutralizing Antibodies
Contrast Media
Blood Proteins
Epidermis
Transgenic Mice
Biological Availability
Molecular weight
Neoplasms
Homeostasis

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine (miscellaneous)
  • Immunology and Microbiology (miscellaneous)
  • Neuroscience (miscellaneous)

Cite this

Sounni, N. E., Dehne, K., Van Kempen, L., Egeblad, M., Affara, N. I., Cuevas, I., ... Coussens, L. M. (2010). Stromal regulation of vessel stability by MMP14 and TGFβ. DMM Disease Models and Mechanisms, 3(5-6), 317-332. https://doi.org/10.1242/dmm.003863

Stromal regulation of vessel stability by MMP14 and TGFβ. / Sounni, Nor E.; Dehne, Kerstin; Van Kempen, Leon; Egeblad, Mikala; Affara, Nesrine I.; Cuevas, Ileana; Wiesen, Jane; Junankar, Simon; Korets, Lidiya; Lee, Jake; Shen, Jennifer; Morrison, Charlotte J.; Overall, Christopher M.; Krane, Stephen M.; Werb, Zena; Boudreau, Nancy; Coussens, Lisa M.

In: DMM Disease Models and Mechanisms, Vol. 3, No. 5-6, 05.2010, p. 317-332.

Research output: Contribution to journalArticle

Sounni, NE, Dehne, K, Van Kempen, L, Egeblad, M, Affara, NI, Cuevas, I, Wiesen, J, Junankar, S, Korets, L, Lee, J, Shen, J, Morrison, CJ, Overall, CM, Krane, SM, Werb, Z, Boudreau, N & Coussens, LM 2010, 'Stromal regulation of vessel stability by MMP14 and TGFβ', DMM Disease Models and Mechanisms, vol. 3, no. 5-6, pp. 317-332. https://doi.org/10.1242/dmm.003863
Sounni NE, Dehne K, Van Kempen L, Egeblad M, Affara NI, Cuevas I et al. Stromal regulation of vessel stability by MMP14 and TGFβ. DMM Disease Models and Mechanisms. 2010 May;3(5-6):317-332. https://doi.org/10.1242/dmm.003863
Sounni, Nor E. ; Dehne, Kerstin ; Van Kempen, Leon ; Egeblad, Mikala ; Affara, Nesrine I. ; Cuevas, Ileana ; Wiesen, Jane ; Junankar, Simon ; Korets, Lidiya ; Lee, Jake ; Shen, Jennifer ; Morrison, Charlotte J. ; Overall, Christopher M. ; Krane, Stephen M. ; Werb, Zena ; Boudreau, Nancy ; Coussens, Lisa M. / Stromal regulation of vessel stability by MMP14 and TGFβ. In: DMM Disease Models and Mechanisms. 2010 ; Vol. 3, No. 5-6. pp. 317-332.
@article{4b9ea8e910374a9d84c571823fd2e2a8,
title = "Stromal regulation of vessel stability by MMP14 and TGFβ",
abstract = "Innate regulatory networks within organs maintain tissue homeostasis and facilitate rapid responses to damage. We identified a novel pathway regulating vessel stability in tissues that involves matrix metalloproteinase 14 (MMP14) and transforming growth factor beta 1 (TGFβ1). Whereas plasma proteins rapidly extravasate out of vasculature in wild-type mice following acute damage, short-term treatment of mice in vivo with a broadspectrum metalloproteinase inhibitor, neutralizing antibodies to TGFβ1, or an activin-like kinase 5 (ALK5) inhibitor significantly enhanced vessel leakage. By contrast, in a mouse model of age-related dermal fibrosis, where MMP14 activity and TGFβ bioavailability are chronically elevated, or in mice that ectopically express TGFβ in the epidermis, cutaneous vessels are resistant to acute leakage. Characteristic responses to tissue damage are reinstated if the fibrotic mice are pretreated with metalloproteinase inhibitors or TGFβ signaling antagonists. Neoplastic tissues, however, are in a constant state of tissue damage and exhibit altered hemodynamics owing to hyperleaky angiogenic vasculature. In two distinct transgenic mouse tumor models, inhibition of ALK5 further enhanced vascular leakage into the interstitium and facilitated increased delivery of high molecular weight compounds into premalignant tissue and tumors. Taken together, these data define a central pathway involving MMP14 and TGFβ that mediates vessel stability and vascular response to tissue injury. Antagonists of this pathway could be therapeutically exploited to improve the delivery of therapeutics or molecular contrast agents into tissues where chronic damage or neoplastic disease limits their efficient delivery.",
author = "Sounni, {Nor E.} and Kerstin Dehne and {Van Kempen}, Leon and Mikala Egeblad and Affara, {Nesrine I.} and Ileana Cuevas and Jane Wiesen and Simon Junankar and Lidiya Korets and Jake Lee and Jennifer Shen and Morrison, {Charlotte J.} and Overall, {Christopher M.} and Krane, {Stephen M.} and Zena Werb and Nancy Boudreau and Coussens, {Lisa M.}",
year = "2010",
month = "5",
doi = "10.1242/dmm.003863",
language = "English (US)",
volume = "3",
pages = "317--332",
journal = "DMM Disease Models and Mechanisms",
issn = "1754-8403",
publisher = "Company of Biologists Ltd",
number = "5-6",

}

TY - JOUR

T1 - Stromal regulation of vessel stability by MMP14 and TGFβ

AU - Sounni, Nor E.

AU - Dehne, Kerstin

AU - Van Kempen, Leon

AU - Egeblad, Mikala

AU - Affara, Nesrine I.

AU - Cuevas, Ileana

AU - Wiesen, Jane

AU - Junankar, Simon

AU - Korets, Lidiya

AU - Lee, Jake

AU - Shen, Jennifer

AU - Morrison, Charlotte J.

AU - Overall, Christopher M.

AU - Krane, Stephen M.

AU - Werb, Zena

AU - Boudreau, Nancy

AU - Coussens, Lisa M.

PY - 2010/5

Y1 - 2010/5

N2 - Innate regulatory networks within organs maintain tissue homeostasis and facilitate rapid responses to damage. We identified a novel pathway regulating vessel stability in tissues that involves matrix metalloproteinase 14 (MMP14) and transforming growth factor beta 1 (TGFβ1). Whereas plasma proteins rapidly extravasate out of vasculature in wild-type mice following acute damage, short-term treatment of mice in vivo with a broadspectrum metalloproteinase inhibitor, neutralizing antibodies to TGFβ1, or an activin-like kinase 5 (ALK5) inhibitor significantly enhanced vessel leakage. By contrast, in a mouse model of age-related dermal fibrosis, where MMP14 activity and TGFβ bioavailability are chronically elevated, or in mice that ectopically express TGFβ in the epidermis, cutaneous vessels are resistant to acute leakage. Characteristic responses to tissue damage are reinstated if the fibrotic mice are pretreated with metalloproteinase inhibitors or TGFβ signaling antagonists. Neoplastic tissues, however, are in a constant state of tissue damage and exhibit altered hemodynamics owing to hyperleaky angiogenic vasculature. In two distinct transgenic mouse tumor models, inhibition of ALK5 further enhanced vascular leakage into the interstitium and facilitated increased delivery of high molecular weight compounds into premalignant tissue and tumors. Taken together, these data define a central pathway involving MMP14 and TGFβ that mediates vessel stability and vascular response to tissue injury. Antagonists of this pathway could be therapeutically exploited to improve the delivery of therapeutics or molecular contrast agents into tissues where chronic damage or neoplastic disease limits their efficient delivery.

AB - Innate regulatory networks within organs maintain tissue homeostasis and facilitate rapid responses to damage. We identified a novel pathway regulating vessel stability in tissues that involves matrix metalloproteinase 14 (MMP14) and transforming growth factor beta 1 (TGFβ1). Whereas plasma proteins rapidly extravasate out of vasculature in wild-type mice following acute damage, short-term treatment of mice in vivo with a broadspectrum metalloproteinase inhibitor, neutralizing antibodies to TGFβ1, or an activin-like kinase 5 (ALK5) inhibitor significantly enhanced vessel leakage. By contrast, in a mouse model of age-related dermal fibrosis, where MMP14 activity and TGFβ bioavailability are chronically elevated, or in mice that ectopically express TGFβ in the epidermis, cutaneous vessels are resistant to acute leakage. Characteristic responses to tissue damage are reinstated if the fibrotic mice are pretreated with metalloproteinase inhibitors or TGFβ signaling antagonists. Neoplastic tissues, however, are in a constant state of tissue damage and exhibit altered hemodynamics owing to hyperleaky angiogenic vasculature. In two distinct transgenic mouse tumor models, inhibition of ALK5 further enhanced vascular leakage into the interstitium and facilitated increased delivery of high molecular weight compounds into premalignant tissue and tumors. Taken together, these data define a central pathway involving MMP14 and TGFβ that mediates vessel stability and vascular response to tissue injury. Antagonists of this pathway could be therapeutically exploited to improve the delivery of therapeutics or molecular contrast agents into tissues where chronic damage or neoplastic disease limits their efficient delivery.

UR - http://www.scopus.com/inward/record.url?scp=77952212733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952212733&partnerID=8YFLogxK

U2 - 10.1242/dmm.003863

DO - 10.1242/dmm.003863

M3 - Article

VL - 3

SP - 317

EP - 332

JO - DMM Disease Models and Mechanisms

JF - DMM Disease Models and Mechanisms

SN - 1754-8403

IS - 5-6

ER -